Clinical Trials Directory

Trials / Completed

CompletedNCT04543877

WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
USDA, Western Human Nutrition Research Center · Federal
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if adding dietary fiber, such as inulin, to a diet that does not have enough fiber would raise the levels of potentially beneficial bacteria, such as Bifidobacterium, in the gut. There is evidence to suggest that these microbes can affect gut health and immune response, including to vaccines. The investigators will examine how inulin in the diet (compared to the maltodextrin control) (1) causes changes in the composition and function of the gut microbes, (2) reduces gut inflammation and gut leakiness caused by the vaccine, (3) increases immune response to vaccination, and (4) changes the expression of important adhesion molecules on the surface of white blood cells. Intestinal and whole-body responses will be measured in all participants.

Detailed description

Inulin, a dietary fiber supplement, is known to increase gut levels of potentially beneficial bacteria, including Bifidobacterium that are indigenous to gut microbiomes. Our underlying hypothesis is that the commensal microbiome, including Bifidobacterium, in the proximal colon or distal ileum affects the environment of draining lymph nodes and can thus modulate immune responses, including to vaccines. In the current study, participants will consume 12 grams/day inulin or maltodextrin (control) for 3 weeks before the administration of the Ty21a typhoid fever vaccine, 1 week during the vaccine, and 1 week after the vaccine. Vaccine response will be measured by counting T cells and immunoglobulin G (IgG) or immunoglobulin A (IgA)-secreting plasma cells specific for Ty21a. Gut permeability will be measured at baseline, and before and after the vaccine administration. Systemic inflammation and immune activation will be measured by analyzing blood for markers of inflammation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInulinConsume 12 grams/day of inulin for 5 weeks (Day 9 - 43).
DIETARY_SUPPLEMENTMaltodextrinConsume 12 grams/day of maltodextrin for 5 weeks (Day 9 - 43).
BIOLOGICALTy21a Typhoid Fever VaccineAll participants will receive the vaccine. One capsule is swallowed on alternate days, e.g. days 30, 32, 34, and 36 for a total of 4 capsules.

Timeline

Start date
2022-09-27
Primary completion
2025-06-11
Completion
2025-06-11
First posted
2020-09-10
Last updated
2025-12-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04543877. Inclusion in this directory is not an endorsement.